Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jan 31 2018

CDC Chief Resigns Following Reports She Traded In Tobacco Stocks While Running Agency

"After advising Secretary Azar of both the status of the financial interests and the scope of her recusal, Dr. Fitzgerald tendered, and the Secretary accepted, her resignation," the Department of Health and Human Services said in a statement.

The Hill: CDC Head Resigns After Report She Traded Tobacco Stocks

Centers for Disease Control and Prevent Director Brenda Fitzgerald resigned Wednesday, on day after reports that she traded tobacco stocks while heading the agency. "This morning Secretary Azar accepted Dr. Brenda Fitzgerald’s resignation as Director of the Centers for Disease Control and Prevention," the Department of Health and Human Services said in a statement. (Hellmann, 1/31)

Stat: CDC Director Brenda Fitzgerald Resigns Following Controversy Over Stocks

The statement said that Fitzgerald owns “certain complex financial interests that have imposed a broad recusal limiting her ability to complete all her duties as the CDC director. ”It said that Fitzgerald could not divest from them in a definitive time period, due to the nature of the investments. After advising Azar of the problem, she offered her resignation and he accepted. (Branswell, 1/31)

Politico: CDC Director Resigns Over Financial Conflicts

Buying shares of tobacco companies raised flags because it stood in stark contrast to the CDC’s mission to persuade smokers to quit and keep children from becoming addicted. Fitzgerald's behavior likely broke with ethical norms for public health officials, critics said, and could have posed legal problems if she didn't recuse herself from government activities that could have affected her investments. (1/31)

CNN: CDC Director Fitzgerald Resigns

Fitzgerald was selected for the position in July by then Secretary of Health and Human Services, Dr. Tom Price. (Goldschmidt, 1/31)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF